Leukemia Research
Volume 28, Issue 3 , Pages 217-218, March 2004

Tyrosine kinases in AML: where do they fit in?

Department of Medicine, Division of Hematology/Oncology, Simmons Cancer Center and the Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390-8593, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(03)00268-6

doi:10.1016/j.leukres.2003.07.003

Leukemia Research
Volume 28, Issue 3 , Pages 217-218, March 2004

Article Tools